CAS: 1402709-93-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCT241736 REF: AN-AG01ENWXCAS: 1402709-93-6 | 98% | 161.00 €~613.00 € | Tue 21 May 24 |
 | CCT241736 REF: TM-T4428CAS: 1402709-93-6 | 99.88% | 59.00 €~482.00 € | Tue 28 May 24 |
 | CCT241736 REF: 3D-CGC70993CAS: 1402709-93-6 | Min. 95% | To inquire | Mon 01 Jul 24 |
Ref: AN-AG01ENWX
| 50mg | 161.00 € | |
| 100mg | 272.00 € | |
| 250mg | 613.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
CCT241736
CAS:1402709-93-6
CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant …
Formula:
C22H23Cl2N7
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
456.37
Ref: TM-T4428
| 5mg | 59.00 € | |
| 10mg | 96.00 € | |
| 25mg | 167.00 € | |
| 50mg | 323.00 € | |
| 100mg | 482.00 € | |
| 1ml*10 (DMSO) | 66.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
CCT241736
CAS:1402709-93-6
CCT241736 is an effective dose of a clinical drug that belongs to the class of …
Formula:
C22H23Cl2N7
Purity:
Min. 95%
Molecular weight:
456.37 g/mol
Ref: 3D-CGC70993
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
